- Summary
- Stats & Ratios
- Income Statement
- Balance Sheet
- Cash Flow
- Opinions
Tapestry Pharmaceuticals, Inc.
(NASDAQ:TPPH)- View:
- Quarterly Data
- Annual Data
- Note: All numbers in thousands
| Sep 30, 2007 | |
|---|---|
| Assets | |
| Current Assets | |
| Cash & Equivalents | 5,577 |
| Restricted Cash | — |
| Marketable Securities | 3,781 |
| Accounts Receivable | — |
| Loans Receivable | — |
| Other Receivable | — |
| Receivables | — |
| Raw Materials | — |
| Work in Progress | — |
| Purchased Components | — |
| Finished Goods | — |
| Other Inventories | — |
| Inventories Adjustments and Allowances | — |
| Inventories | — |
| Prepaid Expenses | 351 |
| Current Deferred Income Taxes | — |
| Other Current Assets | — |
| Total Current Assets | 9,709 |
| Land and Improvements | — |
| Building and Improvements | — |
| Machinery Furniture and Equipment | — |
| Construction in Progress | — |
| Other Fixed Assets | 1,578 |
| Total Fixed Assets | 1,578 |
| Gross Fixed Assets | 1,578 |
| Accumulated Depreciation and Depletion | 871 |
| Net Fixed Assets | 707 |
| Intangibles | — |
| Cost in Excess | — |
| Non Current Deferred Income Taxes | — |
| Other Non Current Assets | 1,472 |
| Total Non Current Assets | 2,179 |
| Total Assets | 11,888 |
| Liabilities | |
| Current Liabilities | |
| Accounts Payable | 2,100 |
| Notes Payable | 121 |
| Short Term Debt | — |
| Accrued Expenses | — |
| Accrued Liabilities | 1,428 |
| Deferred Revenues | — |
| Current Deferred Income Tax Liabilities | — |
| Other Current Liabilities | — |
| Total Current Liabilities | 3,649 |
| Non Current Liabilities | |
| Long Term Debt | 22 |
| Capital Lease Obligations | — |
| Deferred Income Tax Liabilities | — |
| Other Non Current Liabilities | — |
| Minority Interest Liabilities | — |
| Preferred Securities of Subsidiary Trust Liabilities | — |
| Preferred Equity Outside Stock Equity | — |
| Total Non Current Liabilities | 3,671 |
| Total Liabilities | 22 |
| Shareholders' Equity | |
| Preferred Stock Equity | — |
| Common Stock Equity | 8,217 |
| Common Par | 125 |
| Additional Paid in Capital | 148,706 |
| Cumulative Translation Adjustment | — |
| Retained Earnings | -140,595 |
| Treasury Stock | — |
| Other Equity Adjustments | -19 |
| Total Capitalization | 8,239 |
| Cash Flow | -21,014 |
| Working Capital | 6,060 |
| Free Cash Flow | -13,050 |
| Invested Capital | 8,239 |
| Total Equity | 8,217 |
| Total Liabilities and Stock Equity | 11,888 |